BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 11876711)

  • 1. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.
    Mason J; Axon AT; Forman D; Duffett S; Drummond M; Crocombe W; Feltbower R; Mason S; Brown J; Moayyedi P;
    Aliment Pharmacol Ther; 2002 Mar; 16(3):559-68. PubMed ID: 11876711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
    Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
    BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
    Ford AC; Forman D; Nathan J; Crocombe WD; Axon AT; Moayyedi P
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1267-75. PubMed ID: 17944741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group.
    Moayyedi P; Feltbower R; Crocombe W; Mason S; Atha P; Brown J; Dowell AC; Richards ID; Axon AT
    Aliment Pharmacol Ther; 2000 Jun; 14(6):719-28. PubMed ID: 10848655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.
    Craig AM; Davey P; Malek M; Murray F
    Pharmacoeconomics; 1996 Jul; 10(1):79-92. PubMed ID: 10160472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.
    Moayyedi P; Feltbower R; Brown J; Mason S; Mason J; Nathan J; Richards ID; Dowell AC; Axon AT
    Lancet; 2000 May; 355(9216):1665-9. PubMed ID: 10905240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation.
    Roderick P; Davies R; Raftery J; Crabbe D; Pearce R; Patel P; Bhandari P
    J Med Screen; 2003; 10(3):148-56. PubMed ID: 14561268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.
    Ford AC; Delaney BC; Forman D; Moayyedi P
    Am J Gastroenterol; 2004 Sep; 99(9):1833-55. PubMed ID: 15330927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
    Gisbert JP; Hermida C; Pajares JM
    Hepatogastroenterology; 2001; 48(41):1383-8. PubMed ID: 11677970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study.
    Zullo A; Rinaldi V; Pugliano F; Diana F; Attili AF
    Am J Gastroenterol; 1997 Nov; 92(11):2029-31. PubMed ID: 9362185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.
    Chiba N; Veldhuyzen Van Zanten SJ; Escobedo S; Grace E; Lee J; Sinclair P; Barkun A; Armstrong D; Thomson AB
    Aliment Pharmacol Ther; 2004 Feb; 19(3):349-58. PubMed ID: 14984382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
    Hansen JM; Wildner-Christensen M; Hallas J; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2008 May; 103(5):1106-13. PubMed ID: 18445098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
    Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
    Hawkey CJ; Tulassay Z; Szczepanski L; van Rensburg CJ; Filipowicz-Sosnowska A; Lanas A; Wason CM; Peacock RA; Gillon KR
    Lancet; 1998 Sep; 352(9133):1016-21. PubMed ID: 9759744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
    Sonnenberg A; Schwartz JS; Cutler AF; Vakil N; Bloom BS
    Arch Intern Med; 1998 Apr; 158(8):852-60. PubMed ID: 9570170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
    Chiba N; Van Zanten SJ; Sinclair P; Ferguson RA; Escobedo S; Grace E
    BMJ; 2002 Apr; 324(7344):1012-6. PubMed ID: 11976244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.
    Moayyedi P; Soo S; Deeks J; Forman D; Mason J; Innes M; Delaney B
    BMJ; 2000 Sep; 321(7262):659-64. PubMed ID: 10987767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection.
    Gwee KA; Teng L; Wong RK; Ho KY; Sutedja DS; Yeoh KG
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):417-24. PubMed ID: 19369829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.